Quasar Medical Acquires Nordson’s Manufacturing Businesses to Enhance Medical Device Solutions

Quasar Medical's Strategic Acquisition: A Leap Towards Comprehensive Medical Device Solutions

Quasar Medical makes a significant stride in the medical device manufacturing sector with its acquisition of Nordson Corporation's design and development contract manufacturing businesses, located in Galway, Ireland, and Tecate, Mexico. This development is pivotal as it transforms Quasar into a fully integrated Contract Development and Manufacturing Organization (CDMO), positioning the company to offer comprehensive concept-to-commercialization solutions for medical device original equipment manufacturers (OEMs) and innovators. By acquiring these two facilities, Quasar not only enhances its operational capabilities but also expands its workforce by nearly 200 skilled employees, including development engineers and technicians. This influx of talent will enable Quasar to better meet the growing demands of the MedTech industry.

The Galway facility is poised to become a center of innovation, focusing on advanced product design, prototyping, and clinical innovation. This strategic positioning in a key MedTech region allows Quasar to foster closer collaborations with customers and suppliers throughout the product lifecycle. CEO Alex Wallstein underscores the importance of this acquisition in enhancing Quasar’s global reach. By solidifying partnerships and promoting innovation, Quasar aims to accelerate the time it takes to bring new medical devices to market. Meanwhile, the Tecate location will strengthen Quasar's capabilities in high-volume manufacturing, allowing for smoother transitions from development to commercialization—crucial for meeting the needs of OEMs who require both quality and efficiency.

Furthermore, Quasar's COO, Aviel Bohnik, highlights that the integration of Nordson Medical’s capabilities positions Quasar as a strategic partner in the industry rather than merely a manufacturer. This shift enables Quasar to provide a differentiated platform that combines innovation, scalability, and operational excellence. As the company adopts this comprehensive approach, it reinforces its commitment to delivering high-value solutions across key global regions, particularly in the complex landscape of interventional devices.

In addition to enhancing its service offerings, Quasar's acquisition reflects a broader trend in the MedTech industry where companies seek to streamline operations and enhance innovation through strategic partnerships and acquisitions. As the demand for minimally invasive medical devices continues to rise, Quasar is well-positioned to capitalize on these market opportunities.

With its newly expanded capabilities, Quasar Medical is set to redefine the standards of collaboration and innovation in medical device manufacturing, signaling a promising future for the company and its stakeholders.